Form 4: United Therapeutics Director Nilda Mesa Sells 224 Shares
SEC Form 4
Nilda Mesa, a director at United Therapeutics Corp, sold 224 shares of common stock at a price of $412.278 per share on November 8, 2024.
Summary
- On November 8, 2024, Nilda Mesa, a director of United Therapeutics Corp, sold 224 shares of the company's common stock.
- The sale price was $412.278 per share.
- Following the transaction, Nilda Mesa directly owns 5,783 shares of United Therapeutics Corp.
Sentiment
Score: 5
Explanation: This is a neutral event. A director selling shares doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This is a routine disclosure of a transaction by a company insider. It's common for directors and officers to buy and sell shares of their company's stock.
Stakeholder Impact
- The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the transaction.
Key Dates
| Date | Description |
|---|---|
| 11/08/2024 | Date of the stock sale transaction |
| 11/11/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.